Novo Nordisk’s Wegovy gains CDSCO approval for MASH in India, marking a key GLP-1 expansion into liver disease, strengthening its role in metabolic disorder treatment.
A wave of strategic deals, policy momentum, and technological breakthroughs defined the week for India’s drug manufacturers
A recent drug recall involving oncology products has once again brought global pharmaceutical quality standards into focus, recalls are not necessarily indicators of systemic failure but rather evidence of active monitoring and corrective mechanisms
The suspension of Premarin vaginal cream by Pfizer has drawn attention for its immediate impact, and also signals in evolving priorities in the Indian market
Merck’s cholesterol pill is poised to reshape the global cardiovascular drug landscape, this comes with the latest approval from the U.S. Food and Drug Administration for its first-in-class oral PCSK9 inhibitor
India’s pharmaceutical sector is entering a transformative phase with AI and biologics powering the pharma innovation that will reshaping the industry’s future
The hidden ingredient powering the world’s next TB vaccine is not the antigen itself. But a highly specialized immune-boosting component known as the AS01E adjuvant
The fight against tuberculosis is no longer just about better medicines or advanced diagnostics, rather, it is increasingly about speed
India’s pharmaceutical ambitions are entering a decisive phase with the government announcing Rs 1,500 crore assistance fund
The idea of a 20-minute contact lens could change how people receive vision correction. Researchers have developed 3D printed contact lenses that can be customized for each eye in about 20 minutes.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")